Companies / Repligen Corp / Activity
Activity — Repligen Corp
34 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | Hunt Anthony Director | Other | Common Stock | $1.24M | -10K -10.00% | 89,062 0.16% of shares | low |
| Mar 2, 2026 | Bylund James Executive | Other | Common Stock | $304.1K | -2K -12.14% | 17,609 0.03% of shares | low |
| Mar 2, 2026 | Loeillot Olivier CEO | Other | Common Stock | $201.2K | -2K -4.53% | 33,944 0.06% of shares | low |
| Feb 27, 2026 | Bylund James Executive | Other | Common Stock | $190.3K | -1K -6.87% | 20,042 0.04% of shares | low |
| Mar 2, 2026 | Kuriyel Ralf Executive | Other | Common Stock | $115.3K | -923 -5.91% | 14,695 0.03% of shares | low |
| May 7, 2026 | Muir Glenn P Director | Exercise | Common Stock | $94.3K | +2K +6.65% | 39,056 0.07% of shares | low |
| Mar 2, 2026 | Garland Jason K Executive | Other | Common Stock | $89.4K | -715 -5.48% | 12,341 0.02% of shares | low |
| Feb 27, 2026 | Kuriyel Ralf Executive | Other | Common Stock | $57.2K | -444 -2.76% | 15,618 0.03% of shares | low |
| Feb 27, 2026 | Loeillot Olivier CEO | Other | Common Stock | $44.3K | -344 -0.96% | 35,554 0.06% of shares | low |
| Feb 27, 2026 | Garland Jason K Executive | Other | Common Stock | $42.1K | -327 -2.44% | 13,056 0.02% of shares | low |
| Mar 2, 2026 | Douglass Brian Robb Executive | Other | Common Stock | $27.6K | -221 -2.59% | 8,319 0.01% of shares | low |
| Mar 4, 2026 | Bylund James Executive | Other | Common Stock | $7.8K | -62 -0.35% | 17,672 0.03% of shares | low |
| Mar 4, 2026 | Kuriyel Ralf Executive | Other | Common Stock | $5.3K | -42 -0.28% | 14,778 0.03% of shares | low |
| May 14, 2026 | Madaus Martin D Director | Grant | Common Stock | $0 | +995 +17.81% | 6,581 0.01% of shares | low |
| May 14, 2026 | Barthelemy Nicolas Director | Grant | Common Stock | $0 | +995 +22.40% | 5,436 <0.01% of shares | low |
| May 14, 2026 | Dawes Karen a Director | Grant | Common Stock | $0 | +995 +1.08% | 92,816 0.16% of shares | low |
| May 14, 2026 | Muir Glenn P Director | Grant | Common Stock | $0 | +995 +2.55% | 40,051 0.07% of shares | low |
| Dec 31, 2025 | Douglass Brian Robb Executive | Grant | Common Stock | $0 | +2K +36.60% | 8,540 0.02% of shares | low |
| Mar 5, 2026 | Loeillot Olivier CEO | Grant | Common Stock | $0 | +24K +71.10% | 58,078 0.10% of shares | low |
| Mar 5, 2026 | Bylund James Executive | Grant | Common Stock | $0 | +8K +43.86% | 25,423 0.05% of shares | low |
| Mar 4, 2026 | Bylund James Executive | Grant | Common Stock | $0 | +125 +0.71% | 17,734 0.03% of shares | low |
| Mar 5, 2026 | Garland Jason K Executive | Grant | Common Stock | $0 | +8K +62.81% | 20,092 0.04% of shares | low |
| Mar 5, 2026 | Kuriyel Ralf Executive | Grant | Common Stock | $0 | +5K +35.76% | 20,062 0.04% of shares | low |
| Mar 4, 2026 | Kuriyel Ralf Executive | Grant | Common Stock | $0 | +125 +0.85% | 14,820 0.03% of shares | low |
| May 14, 2026 | Madaus Martin D Director | Grant | Stock Option (Right to Buy) | — | +2K | 2,239 <0.01% of shares | low |
| May 14, 2026 | Barthelemy Nicolas Director | Grant | Stock Option (Right to Buy) | — | +2K | 2,239 <0.01% of shares | low |
| May 14, 2026 | Dawes Karen a Director | Grant | Stock Option (Right to Buy) | — | +2K | 2,239 <0.01% of shares | low |
| May 14, 2026 | Muir Glenn P Director | Grant | Stock Option (Right to Buy) | — | +2K | 2,239 <0.01% of shares | low |
| May 7, 2026 | Muir Glenn P Director | Exercise | Stock Option (Right to Buy) | — | +2K | 2,434 <0.01% of shares | low |
| Dec 31, 2025 | Douglass Brian Robb Executive | Grant | Stock Option (Right to Buy) | — | +2K | 2,143 <0.01% of shares | low |
| Mar 5, 2026 | Loeillot Olivier CEO | Grant | Stock Option (Right to Buy) | — | +26K | 25,890 0.05% of shares | low |
| Mar 5, 2026 | Bylund James Executive | Grant | Stock Option (Right to Buy) | — | +8K | 8,315 0.01% of shares | low |
| Mar 5, 2026 | Garland Jason K Executive | Grant | Stock Option (Right to Buy) | — | +8K | 8,315 0.01% of shares | low |
| Mar 5, 2026 | Kuriyel Ralf Executive | Grant | Stock Option (Right to Buy) | — | +6K | 5,669 0.01% of shares | low |